• Select Country or region

Sesderma signs agreement to commercialize botulinum toxin


Dr. Gabriel Serrano, president and founder of Sesderma, and the Korean company Huons Intl based in Seoul, have signed an agreement for the distribution of the botulinum toxin under the Sesderma brand. The first phase of collaboration covers the entire European territory, and may be extended to other markets such as Latin America and Russia, once the registration period in Europe has come to an end.

This agreement is a great step for Sesderma, as it will allow the company to compete internationally with a unique and complete portfolio of treatments, and position itself as a reference of integral and innovative solutions in the field of dermatology and aesthetic medicine.


Bootstrap Thumbnail First
Bootstrap Thumbnail Second